emeis Société anonyme (BATS-CHIXE:EMEISP) - Stock Price, News & Analysis

EMEISP Stock Overview

Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. More details

EMEISP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	2/6
Financial Health	0/6
Dividends	0/6

Rewards

Trading at 95.5% below our estimate of its fair value

Revenue is forecast to grow 6.27% per year

Became profitable this year

Risk Analysis

Shareholders have been substantially diluted in the past year

Debt is not well covered by operating cash flow

Earnings are forecast to decline by an average of 106.1% per year for the next 3 years

High level of non-cash earnings

+ 1 more risk

emeis Société anonyme Competitors

CVS Group

AIM:CVSG

UK£596.9m

Spire Healthcare Group

LSE:SPI

UK£885.2m

Mediclinic International

LSE:MDC

UK£3.7b

Craneware

AIM:CRW

UK£812.4m

Price History & Performance

Summary of all time highs, changes and price drops for emeis Société anonyme
Historical stock prices
Current Share Price	€13.34
52 Week High	€17.10
52 Week Low	€10.92
Beta	0.72
11 Month Change	0%
3 Month Change	0.99%
1 Year Change	n/a
33 Year Change	-99.99%
5 Year Change	-99.99%
Change since IPO	-99.95%

Recent updates

Shareholder Returns

	EMEISP	GB Healthcare	GB Market
7D	0%	-2.5%	0.8%
1Y	n/a	-23.5%	6.6%

Return vs Industry: Insufficient data to determine how EMEISP performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how EMEISP performed against the UK Market.

Price Volatility

Is EMEISP's price volatile compared to industry and market?
EMEISP volatility
EMEISP Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.4%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.3%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: EMEISP's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine EMEISP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	78,000	Laurent Guillot	www.emeis-group.com

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state.

emeis Société anonyme Fundamentals Summary

How do emeis Société anonyme's earnings and revenue compare to its market cap?
EMEISP fundamental statistics
Market cap	€825.82m
Earnings (TTM)	€1.47b
Revenue (TTM)	€5.43b

0.6x

P/E Ratio

0.2x

P/S Ratio

Is EMEISP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EMEISP income statement (TTM)
Revenue	€5.43b
Cost of Revenue	€4.78b
Gross Profit	€648.53m
Other Expenses	-€820.05m
Earnings	€1.47b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	9.12
Gross Margin	11.94%
Net Profit Margin	27.04%
Debt/Equity Ratio	233.1%

How did EMEISP perform over the long term?

See historical performance and comparison

EMEISP Stock Overview

Rewards

Risk Analysis

emeis Société anonyme Competitors

AIM:CVSG

UK£596.9m

LSE:SPI

UK£885.2m

LSE:MDC

UK£3.7b

AIM:CRW

UK£812.4m

Price History & Performance

Recent News & Updates

Orpea SA, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: €0.13 (vs €62,330 loss in FY 2022)

New major risk - Revenue and earnings growth

Orpea SA has completed a Follow-on Equity Offering in the amount of €390.019673 million.

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Recent updates

Orpea SA, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: €0.13 (vs €62,330 loss in FY 2022)

New major risk - Revenue and earnings growth

Orpea SA has completed a Follow-on Equity Offering in the amount of €390.019673 million.

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea SA announced that it expects to receive €390.019673 million in funding

Orpea Sa Appoints Méka Brunel as Independent Non-Executive Director

Orpea SA has filed a Follow-on Equity Offering in the amount of €1.2 billion.

Orpea SA(ENXTPA:ORPDS) dropped from SBF 120 Index

Orpea SA has filed a Follow-on Equity Offering in the amount of €3.884212 billion.

Orpea SA, Annual General Meeting, Dec 22, 2023

Orpea SA Provides Earnings Guidance for the Full Year 2023; Provides Consolidated Revenue Guidance for the Years 2024 and 2025

Orpea SA to Report First Half, 2023 Results on Oct 11, 2023

New minor risk - Market cap size

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

An Unknown buyer acquired portfolio of four recently built retirement homes In Austria from Orpea SA (ENXTPA:ORP) for €55 million.

Orpea SA Provides Financial Guidance for 2023

New major risk - Negative shareholders equity

Full year 2022 earnings released: €62.33 loss per share (vs €1.01 profit in FY 2021)

Adoro SIA signed an agreement to acquire Retirement Home and Entire Scope of Activities in Latvia from Orpea SA (ENXTPA:ORP).

Caisse des Dépôts et Consignations and a representative group of creditors agreed to acquire a 50.2% stake in Carver Maritime Manatee.

Orpea Sa Announces Revenue Guidance for Year Ending 31 December 2022

First half 2022 earnings released: EPS: €0 (vs €1.59 in 1H 2021)

Orpea SA(ENXTPA:ORP) dropped from FTSE All-World Index (USD)

Investor sentiment deteriorated over the past week

Orpea S.A Appoints Laure Duhot as Non-Executive Director

Investor sentiment improved over the past week

Syntrus Achmea Real Estate & Finance signed agreement to acquire portfolio of 32 retirement homes located in the Netherlands from Orpea SA (ENXTPA:ORP) for EUR 125 million.

ORPEA Announces Major Changes in its Board of Directors

Full year 2021 earnings released: EPS: €1.01 (vs €2.48 in FY 2020)

Orpea SA to Report First Half, 2022 Results on Sep 21, 2022

Investor sentiment deteriorated over the past week

ORPEA Appoints Laurent Guillot as CEO

Orpea Announces CEO Changes

Investor sentiment deteriorated over the past week

Orpea Provides Earnings Guidance for the Full Year 2021

First half 2021 earnings released

Upcoming dividend of €0.90 per share

Orpea SA Reiterate Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released

Orpea SA Proposes Dividend for Financial Year 2020

New 90-day low: €102

Orpea SA to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day high: €109

ORPEA Société Anonyme (ENXTPA:ORP) agreed to acquire remaining 55% stake in Groupe Sinoue - Sarl.

Orpea SA (ENXTPA:ORP) acquired 50% stake in Brindley Healthcare Limited.

Icade SA (ENXTPA : ICAD) agreed to acquire Portfolio of 9 Healthcare Facilities in Germany & France from Orpea SA (ENXTPA : ORP) for €145 million.

Shareholder Returns

Price Volatility

About the Company

emeis Société anonyme Fundamentals Summary

0.6x

0.2x

Earnings & Revenue